Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs.

Reperfusion injury is the major cause of early morbidity and mortality after lung transplantation. This complication has been experimentally linked to dysfunction of pulmonary surfactant. Therefore, the hypothesis that reperfusion injury might be preventable by exogenous surfactant treatment was tested. Left lungs of minipigs were exposed to 120 min of ischaemia, and the lungs were then reperfused for up to 7 h. Animals were divided into a control group and a surfactant group (n=5 each). The surfactant group received 50 mg x kg(-1) Alveofact intrabronchially via a bronchoscope at the beginning of the ischaemic period. Bronchoalveolar lavage was performed at baseline before ischaemia and 90 min after reperfusion. Surfactant treatment significantly improved short-term survival. Pulmonary vascular resistance increased markedly in control animals leading to right heart failure and death within 3 h after reperfusion whereas the surfactant-treated animals survived the 7 h observation period. After reperfusion, alveolar accumulation of neutrophils and exuded proteins was present in both groups to the same extent. Surfactant activity after reperfusion deteriorated markedly in the control group but was preserved in the surfactant group. In conclusion, early surfactant treatment alleviates the deterioration of surfactant function and improves survival in this minipig model of ischaemia-reperfusion injury.

[1]  P. R. Miles,et al.  Alveolar type II cell cNOS activity and ATP levels are increased by lung surfactant or DPPC vesicles. , 1997, The American journal of physiology.

[2]  H. Schäfers,et al.  Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. , 1997, The Journal of thoracic and cardiovascular surgery.

[3]  H. Blau,et al.  Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. , 1997, The American journal of physiology.

[4]  K. Steinberg,et al.  Bovine surfactant therapy for patients with acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.

[5]  J. T. Cope,et al.  Intratracheal surfactant administration preserves airway compliance during lung reperfusion. , 1996, The Annals of thoracic surgery.

[6]  E. Bacha,et al.  Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group. , 1996, The Journal of thoracic and cardiovascular surgery.

[7]  W. Seeger,et al.  Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. , 1996, American journal of respiratory and critical care medicine.

[8]  R. Novick,et al.  Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. , 1996, American journal of respiratory and critical care medicine.

[9]  J. Hohlfeld,et al.  Surfactant: a review of its functions and relevance in adult respiratory disorders. , 1996, Respiratory medicine.

[10]  G. Hofstede,et al.  Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. , 1996, American journal of respiratory and critical care medicine.

[11]  R. Bolman,et al.  SURFACTANT DYSFUNCTION IN LUNG PRESERVATION , 1995, Transplantation.

[12]  A. Haverich,et al.  Nebulized synthetic surfactant in reperfusion injury after single lung transplantation. , 1995, The Journal of thoracic and cardiovascular surgery.

[13]  M. Pasque,et al.  Pulmonary Transplantation , 1995, Annals of surgery.

[14]  S. Oetomo,et al.  The function of surfactant is impaired during the reimplantation response in rat lung transplants. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  R. Novick,et al.  Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation. , 1994, The Journal of thoracic and cardiovascular surgery.

[16]  R. Novick,et al.  Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. , 1993, The American review of respiratory disease.

[17]  W. Seeger,et al.  Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. , 1993, The European respiratory journal.

[18]  J. Harwood,et al.  Degradation of human and rat surfactant apoprotein by neutrophil elastase and cathepsin G. , 1993, Biochemical Society transactions.

[19]  E. Baráth,et al.  Fundamentals of Biostatistics. , 1992 .

[20]  A. Menkis,et al.  New trends in lung preservation: a collective review. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  C. R. Reed,et al.  Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. , 1991, The Journal of clinical investigation.

[22]  G. Enhorning,et al.  Inhibition of pulmonary surfactant function by phospholipases. , 1991, Journal of applied physiology.

[23]  B. Robertson,et al.  Inactivation of Exogenous Surfactant by Pulmonary Edema Fluid , 1991, Pediatric Research.

[24]  W. Klepetko,et al.  Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of L-carnitine application. , 1990, The Journal of thoracic and cardiovascular surgery.

[25]  S. Hawgood,et al.  Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. , 1989, Biochimica et biophysica acta.

[26]  G. Enhorning,et al.  Artificial pulmonary surfactant inhibited by proteins. , 1987, Journal of applied physiology.

[27]  S. Jamieson,et al.  Improved lung preservation using Euro-Collins solution for flush-perfusion. , 1986, The Thoracic and cardiovascular surgeon.

[28]  W. Seeger,et al.  Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. , 1985, Journal of applied physiology.

[29]  C. Bredenberg,et al.  High surface tension pulmonary edema. , 1983, The Journal of surgical research.

[30]  G. Enhorning,et al.  Pulsating bubble technique for evaluating pulmonary surfactant. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.

[31]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[32]  G. R. Bartlett.  Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[33]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  W. Seeger,et al.  Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. , 1996, American journal of respiratory and critical care medicine.

[35]  S. Iversen.  [Surgical treatment of thromboembolism-induced pulmonary hypertension]. , 1994, Zeitschrift fur Kardiologie.